Page 18 - Biomedical Device Technology Science Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biomedical device technology science communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biomedical Device Technology Science Communications Today - Breaking & Trending Today

New Study Shows Peer Pressure Could Help Teens Make Safer Choices

Date Time
New Study Shows Peer Pressure Could Help Teens Make Safer Choices
Peer pressure, a powerful influence in the lives of students, has rather negative connotations in society, which includes the influence of peers on juvenile delinquency and the use of alcohol or cigarettes. According to a new study, affiliated with UNIST, observing social peers making safe choices may lead some teens to make healthy decisions than they would otherwise.
Professor Dongil Chung from the Department of Biomedical Engineering at UNIST, in collaboration with neuroscientists from Virginia Tech in the United States, has examined the influential power of safe teenagers among peers in a new neuroeconomics study. Using quantitative model-based analyses, they identified behavioral and neural evidence that observing others’ safe choices increases the subjective value and selection of safe options for substance-naïve relative to substance-exposed adolescents. ....

United States , Dongil Chung , Marka Orloff , Nina Lauharatanahirun , National Institutes Of Health , Department Of Biomedical Engineering , Proceedings Of The National Academy Science , Biomedical Engineering , Virginia Tech , National Academy , National Institutes , Brain Activity , ஒன்றுபட்டது மாநிலங்களில் , மார்க்கா ஆர்லாஃப் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , துறை ஆஃப் உயிர் மருத்துவ பொறியியல் , உயிர் மருத்துவ பொறியியல் , வர்ஜீனியா தொழில்நுட்பம் , தேசிய கலைக்கழகம் , தேசிய நிறுவனங்கள் , மூளை நடவடிக்கை ,

Deep learning amyotrophic lateral sclerosis by taking pictures

Kyoto University
A team of scientists led by CiRA Professor Haruhisa Inoue reports the combination of deep learning and iPS cell technology for the diagnosis of amyotrophic lateral sclerosis (ALS).
For many devasting neurological diseases like Alzheimer’s disease and amyotrophic lateral sclerosis (ALS), patients are diagnosed only after becoming symptomatic. However, the evidence of memory and muscle loss is seen only after the disease has progressed to irreversible states. Researchers are therefore exploring ways to identify patients well before they become symptomatic, which could allow for wider clinical options.
“If we can catch the disease at the reversible stage, we may reverse and cancel the disease.” said CiRA Prof. Haruhisa Inoue, a specialist of ALS research using iPS cells. ....

Hideshi Kawakami , Haruhisa Inoue , Keiko Imamura , Yuichiro Yada , Mitsuya Morita , Kayoko Tsukita , Ryosuke Takahashi , Ayako Nagahashi , Masanori Nakagawa , Akihiro Kawata , Yuishin Izumi , Takayo Arisato , Department Of Clinical Neuroscience , Tokushima University Graduate School , Bioresource Research Center , School Of Medicine , Department Of Neurology , Institute For Advancement Of Clinical , Hiroshima University , Department Of Epidemiology , Kyoto University Hospital , Institute Of Biomedical Sciences , National Hospital Organization Minamikyusyu , Ps Cells Team , Department Of Internal Medicine , Ps Cell Research ,

New funding for storytelling project to inspire future engineers

'Engineer the Story', run in partnership with the Ideas Foundation, helps engineers create digital stories to bring their research to life. Supported by. ....

United Kingdom , Peterw Mcowan , Richard Pickersgill , Heather Macrae , Tina Chowdhury , Queen Mary , Amanda Murphy , National Film , Storyfutures Academy , Television School , Train The Trainer Initiative Of Storyfutures Academy , Royal Holloway University Of London , Queen Mary University , Ideas Foundation , Royal Academy Of Engineering , United Kingdom National Centre For Immersive Storytelling , Trainer Initiative , National Centre , Immersive Storytelling , Royal Holloway University , Materials Science , Electronic Engineering , Chief Executive , Honorary Fellow , Executive Producer , Royal Academy ,

Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences

Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences
Vancouver, British Columbia (Newsfile Corp. - February 24, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (
Entheon or the
Company ), a biotechnology company focused on developing psychedelic medicines to treat addiction, provides a production update on HaluGen Life Sciences Inc. (
HaluGen ), a wholly-owned subsidiary of Entheon, which is in the business of developing and commercializing a genetic test designed to identify specific DNA biomarkers in order to gauge the risk and potential of adverse reactions toward hallucinogenic drugs.
Following the Company s announcement dated January 14, 2021, detailing Entheon s acquisition of HaluGen, the Company confirms that HaluGen s proprietary psychedelics genetic test kit and technology platform has completed research and development and is nearing commercial production. ....

United States , United Kingdom , British Columbia , Timothy Ko , Joseph Cullen , Product Development Agreement , Halugen Life Sciences Inc , Entheon Biomedical Corp , British Columbia Newsfile Corp , Lobo Genetics Inc , European Union , Canadian Securities Exchange , Psychedelics Genetic , Halugen Life Sciences , Lobo Genetics , Chief Executive Officer , Product Development , Investor Relations , Crystal Quast , Forward Looking , Compensation Shares , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் கொலம்பியா , தீமோத்தேயு கோ , ஜோசப் கல்லன் ,

Renewed funding for national childhood arthritis research centre

Date Time
Renewed funding for national childhood arthritis research centre
The UK’s first and only research centre dedicated to testing better and more effective drug treatments for children with arthritis and related conditions has secured a further three years of funding from the charity Versus Arthritis.
The Experimental Arthritis Treatment Centre for Children (EATC4Children) is based in Liverpool at Alder Hey Children’s NHS Foundation Trust and the University of Liverpool.
Since launching in 2014 the EATC4Children has led a wide range of studies including the landmark APTITUDE trial to improve treatment for children with the severe inflammatory eye condition uveitis, and a major programme of translational research into childhood lupus. ....

City Of , United Kingdom , Michael Beresford , Louise Kenny , Neha Issar Brown , Faculty Of Health , University Hospitals Bristol , University Of Liverpool , University Of Sheffield , Experimental Arthritis Treatment Centre For Children , Life Sciences , University Of Bristol , Professor Of Child Health , Experimental Arthritis Treatment Centre , Alder Hey Children , Child Health , Versus Arthritis , Versus Arthriti Director , Versus Arthriti , Executive Pro Vice Chancellor , Alder Hey , Professor Michael Beresford , Professor Beresford , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , மைக்கேல் பெரெஸ்போர்டு ,